Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Plans are more likely to cover GLP-1s when theyre prescribed for type 2 diabetes than when theyre used for weight loss
When Does It Make Sense to Switch
In the Liraglutide Efficacy and Action in Diabetes (LEAD) programme (61), a total of 154 patients with T2D within the LEAD-2 trial participated in a sub-study to assess liver fat content by the liver-to-spleen attenuation ratio at a computer tomography (CT) scan
You can add personal funds if needed to cover any additional costs
10.1210/jendso/bvab048.800 11 BourezaneH.KastlerB.KantelipJ.-P
US$ 25.28
US$ 20.84
US$ 20.48
US$ 20.46
